07:00 , Oct 24, 2016 |  BC Week In Review  |  Company News

StemImmune, Accurexa deal

Accurexa and StemImmune partnered to develop stem cell-mediated immunotherapies to treat brain cancer. StemImmune referred inquiries to Accurexa, which declined to disclose financial terms. StemImmune Inc., San Diego, Calif.  Accurexa Inc. (OTCQX:ACXA), Newark, Del.  Business: Cancer, Drug delivery  ...
07:00 , Sep 19, 2016 |  BC Week In Review  |  Company News

Accurexa, DelMar Pharma deal

DelMar and Accurexa partnered to develop Accurexa’s ACX-31 implantable polymer wafer to locally deliver DelMar’s VAL-083 in combination with temozolomide and/or carmustine to treat brain cancer and other solid tumors. The partners will share undisclosed...